These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 5714262)

  • 1. [Liberation of alpha-methylnorepinephrine by sympathetic activity in humans following application of alpha-methyldopa].
    Muscholl E; Lindmar R; Rahn KH
    Verh Dtsch Ges Inn Med; 1968; 74():1164-6. PubMed ID: 5714262
    [No Abstract]   [Full Text] [Related]  

  • 2. Studies on the formation of alpha-methylnoradrenaline in hypertensive patients treated with alpha-methyldopa.
    Muscholl E; Rahn KH
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 259(2):215-6. PubMed ID: 4232699
    [No Abstract]   [Full Text] [Related]  

  • 3. Liberation of alpha-methyldopamine as a "false" sympathetic transmitter after pretreatment of cats with alpha-methyldopa and disulfiram.
    Thoenen H; Haefely W; Gey KF; Hürlmann A
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 258(2):181-96. PubMed ID: 4385111
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of rest and physical activity on the urinary excretion of noradrenaline and alpha-methylnoradrenaline in human subjects treated with alpha-methyldopa.
    Lindmar R; Muscholl E; Rahn KH
    Eur J Pharmacol; 1968 Feb; 2(4):317-9. PubMed ID: 5642036
    [No Abstract]   [Full Text] [Related]  

  • 5. [Excretion of catecholamines and amine metabolites of alpha-methyldopa in the urine at different time intervals after the last administered dose].
    Lindmar R; Muscholl E
    Naunyn Schmiedebergs Arch Pharmakol; 1969; 264(3):270-1. PubMed ID: 4242416
    [No Abstract]   [Full Text] [Related]  

  • 6. [Qualitatively and quantitatively different effects of alpha-methyldopa treatment on cats according to a dosage scheme].
    Haefely W; Thoenen H; Hürlimann A
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):25-6. PubMed ID: 4297755
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of alpha-methyldopa on sympathetic nerve function in the pithed rat.
    Doxey JC; Scutt A
    Eur J Pharmacol; 1974 Dec; 29(2):320-3. PubMed ID: 4442449
    [No Abstract]   [Full Text] [Related]  

  • 8. [Effects of alpha-methyldopa and its metabolites on adrenergic vasoregulator centers. In vitro study].
    Cohen Y; Jacquot C; Rapin JR
    Therapie; 1976; 31(2):195-203. PubMed ID: 951674
    [No Abstract]   [Full Text] [Related]  

  • 9. [Antihypertensive mechanism of alpha-methyl-dopa and clinical trials].
    Pirrelli A; Pieri R; Dolce E
    Clin Ter; 1977 Dec; 83(6):583-92. PubMed ID: 608311
    [No Abstract]   [Full Text] [Related]  

  • 10. [Central nervous sympathetic depressant effects of alpha-methyldopa].
    Tauberger G; Kuhn P
    Naunyn Schmiedebergs Arch Pharmakol; 1971; 268(1):33-43. PubMed ID: 4250102
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of methyldopa treatment on peripheral sympathetic nerve function in the dog.
    Lokhandwala MF; Buckley JP; Jandhyala BS
    Eur J Pharmacol; 1975; 32(02):170-8. PubMed ID: 1097259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Depression of behavior and the brain content of alpha-methylnorepinephrine and alpha-methyldopamine following the administration of alpha-methyldopa.
    Dominic JA; Moore KE
    Neuropharmacology; 1971 Jan; 10(1):33-44. PubMed ID: 5569305
    [No Abstract]   [Full Text] [Related]  

  • 13. [Excretion of alpha-methylnoradrenaline in the urine of hypertensive patients during treatment with alpha-methyldopa].
    Muscholl E; Rahn KH
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1967; 257(1):44-5. PubMed ID: 4231857
    [No Abstract]   [Full Text] [Related]  

  • 14. Influence of maternal alpha-methyldopa on sympathetic innervation in the newborn rabbit heart.
    Hoskins EJ; Friedman WF
    Am J Obstet Gynecol; 1980 Jun; 137(4):496-8. PubMed ID: 7386533
    [No Abstract]   [Full Text] [Related]  

  • 15. Metabolism of alpha-methyltyrosine in man: relationship to its potency as an inhibitor of catecholamine biosynthesis.
    Engelman K; Jéquier E; Udenfriend S; Sjoerdsma A
    J Clin Invest; 1968 Mar; 47(3):568-76. PubMed ID: 5637144
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical studies on urinary metanephrine and normetanephrine in various endocrine diseases. 2. Clinical studies on urinary metanephrine and normetanephrine in patients with pheochromyocytoma and a patient with neuroblastoma].
    Shimbo S
    Naika Hokan; 1968 Sep; 15(9):299-310. PubMed ID: 5752086
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of alpha-methyldopa on excretion of noradrenaline metabolites.
    Stott AW; Robinson R
    J Pharm Pharmacol; 1967 Oct; 19(10):690-3. PubMed ID: 4383584
    [No Abstract]   [Full Text] [Related]  

  • 18. [Demonstration of alpha-methylnoradrenaline in the urine of hypertensive patients treated with alpha-methyldopa].
    Muscholl E; Rahn KH
    Klin Wochenschr; 1966 Dec; 44(24):1412-3. PubMed ID: 5994691
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of hydroxyamphetamine (paredrine) on the function of the sympathetic nervous system in normotensive subjects.
    Gill JR; Masson DT; Bartter FC
    J Pharmacol Exp Ther; 1967 Feb; 155(2):288-95. PubMed ID: 6025520
    [No Abstract]   [Full Text] [Related]  

  • 20. Urinary normetadrenaline excretion in essential hypertension.
    Stott AW; Robinson R
    Clin Chim Acta; 1967 May; 16(2):249-52. PubMed ID: 6033516
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.